The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...

Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...

The FDA has agreed to review its decision to remove Eli Lilly’s LLY tirzepatide — the active ingredient used in diabetes drug Mounjaro and obesity drug Zepbound — from its shortage list. During this ...

Hoping your company will begin paying for anti-obesity medications like Wegovy? You may be in luck. A growing number of ...

The FTC sued pharmacy benefit managers over their roles in increasing insulin prices over the past decade. The News talked to ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of ...

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...

The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...

However, the guidance does identify some circumstances where it may be appropriate to prescribe some of the items on the low priority prescribing guidance list. Since the guidance was first published ...

The closer you get to the final stage of diabetes nephropathy, called kidney failure, or end-stage renal disease (ESRD), the more likely you will need specific medications or procedures ... if you are ...

From the Dec 15/Jan 16 issue of Dementia Together magazine, read more about how to manage diabetes when you also have dementia. 'I sometimes forget to take my diabetes medication and insulin ...